File Download

There are no files associated with this item.

  • Find it @ UNIST can give you direct access to the published full text of this article. (UNISTARs only)
Related Researcher

김정범

Kim, Jeong Beom
Molecular Biomedicine Lab.
Read More

Views & Downloads

Detailed Information

Cited time in webofscience Cited time in scopus
Metadata Downloads

Conversion of Mouse Epiblast Stem Cells to an Earlier Pluripotency State by Small Molecules

Author(s)
Zhou, HongyanLi, WenlinZhu, SaiyongJoo, Jin YoungDo, Jeong TaeXiong, WenKim, Jeong BeomZhang, KangSchoeler, Hans R.Ding, Sheng
Issued Date
2010-09
DOI
10.1074/jbc.C110.150599
URI
https://scholarworks.unist.ac.kr/handle/201301/7084
Fulltext
http://www.scopus.com/inward/record.url?partnerID=HzOxMe3b&scp=77956902055
Citation
JOURNAL OF BIOLOGICAL CHEMISTRY, v.285, no.39, pp.29676 - 29680
Abstract
Epiblast stem cells (EpiSCs) are pluripotent cells derived from post-implantation late epiblasts in vitro. EpiSCs are incapable of contributing to chimerism, indicating that EpiSCs are less pluripotent and represent a later developmental pluripotency state compared with inner cell mass stage murine embryonic stem cells (mESCs). Using a chemical approach, we found that blockage of the TGF beta pathway or inhibition of histone demethylase LSD1 with small molecule inhibitors induced dramatic morphological changes in EpiSCs toward mESC phenotypes with simultaneous activation of inner cell mass-specific gene expression. However, full conversion of EpiSCs to the mESC-like state with chimerism competence could be readily generated only with the combination of LSD1, ALK5, MEK, FGFR, and GSK3 inhibitors. Our results demonstrate that appropriate synergy of epigenetic and signaling modulations could convert cells at the later developmental pluripotency state to the earlier mESC-like pluripotency state, providing new insights into pluripotency regulation.
Publisher
AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
ISSN
0021-9258

qrcode

Items in Repository are protected by copyright, with all rights reserved, unless otherwise indicated.